1. Home
  2. GNFT vs EVBN Comparison

GNFT vs EVBN Comparison

Compare GNFT & EVBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • EVBN
  • Stock Information
  • Founded
  • GNFT 1999
  • EVBN 1920
  • Country
  • GNFT France
  • EVBN United States
  • Employees
  • GNFT N/A
  • EVBN N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • EVBN Major Banks
  • Sector
  • GNFT Health Care
  • EVBN Finance
  • Exchange
  • GNFT Nasdaq
  • EVBN Nasdaq
  • Market Cap
  • GNFT 202.6M
  • EVBN 231.8M
  • IPO Year
  • GNFT 2019
  • EVBN N/A
  • Fundamental
  • Price
  • GNFT $3.83
  • EVBN $42.54
  • Analyst Decision
  • GNFT Strong Buy
  • EVBN Hold
  • Analyst Count
  • GNFT 1
  • EVBN 2
  • Target Price
  • GNFT $13.00
  • EVBN $36.25
  • AVG Volume (30 Days)
  • GNFT 12.6K
  • EVBN 22.5K
  • Earning Date
  • GNFT 04-03-2025
  • EVBN 02-04-2025
  • Dividend Yield
  • GNFT N/A
  • EVBN 3.06%
  • EPS Growth
  • GNFT N/A
  • EVBN N/A
  • EPS
  • GNFT 0.47
  • EVBN 2.16
  • Revenue
  • GNFT $86,225,222.00
  • EVBN $66,970,000.00
  • Revenue This Year
  • GNFT $145.20
  • EVBN N/A
  • Revenue Next Year
  • GNFT N/A
  • EVBN N/A
  • P/E Ratio
  • GNFT $7.98
  • EVBN $20.01
  • Revenue Growth
  • GNFT 175.45
  • EVBN N/A
  • 52 Week Low
  • GNFT $3.35
  • EVBN $24.07
  • 52 Week High
  • GNFT $6.42
  • EVBN $46.21
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 48.44
  • EVBN 42.98
  • Support Level
  • GNFT $3.69
  • EVBN $43.37
  • Resistance Level
  • GNFT $4.03
  • EVBN $44.37
  • Average True Range (ATR)
  • GNFT 0.16
  • EVBN 0.78
  • MACD
  • GNFT -0.00
  • EVBN -0.11
  • Stochastic Oscillator
  • GNFT 24.59
  • EVBN 19.08

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About EVBN Evans Bancorp Inc.

Evans Bancorp Inc is a financial holding company. Through its subsidiaries, it provides various banking services to consumers and commercial customers in the USA. The firm operates in two segments, Banking Activities and Insurance Agency Activities. The banking business segment includes both commercial and consumer banking services, including lending and depository services and offering non-deposit investment products, such as annuities and mutual funds. The insurance agency segment includes the activities of selling various premium-based insurance policies on a commission basis, including business and personal insurance, employee benefits, surety bonds, risk management, life, disability and long-term care coverage, and providing claims adjusting services to various insurance companies.

Share on Social Networks: